Physician profile
Seung Lee
NPI 1750313011
$2,842.20
in general payments reported to CMS, 2019-2025
12 companies · $341 in 2025
The $341 reported for 2025 was more than what a typical Otolaryngology provider received nationally (typical 2025 total: $317).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $273 · 2020: $92.90 · 2021: $423 · 2022: $329 · 2023: $824 · 2024: $559 · 2025: $341.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,724.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,723.76 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Acclarent, INC | $647.43 | 2019-2024 | Relieva Spinplus, Acclarent Aera, Trudi Nav Cable |
| Regeneron Healthcare Solutions, INC. | $596.38 | 2019-2025 | Dupixent |
| Stryker Corporation | $394.46 | 2021-2025 | Scopis Ent, Xpress Loprofile |
| Glaxosmithkline, LLC. | $357.64 | 2020-2025 | Nucala |
| Intersect Ent, INC. | $239.30 | 2020-2022 | |
| Genzyme Corporation | $175.66 | 2023-2025 | |
| Allergan, INC. | $148.15 | 2022 | |
| Aerin Medical INC. | $130.94 | 2023 | |
| Smith+Nephew, INC. | $78.84 | 2019-2021 | |
| Integra Lifesciences Corporation | $51.94 | 2024 | Trudi Probe, Inspira Air, Acclarent Aera |
| Kowa Pharmaceuticals America, INC. | $21.46 | 2023 | Seglentis |
1 company reported research payments only; those appear in the research section below.
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Seung Lee listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.